참고문헌
- Archer DF, Hendrix S, Gallagher JC, et al. Endometrial effects of tibolone. J Clin Endocriol Metab, 92:911-918, 2007. https://doi.org/10.1210/jc.2006-2207
- Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med, 355:125-137, 2006. https://doi.org/10.1056/NEJMoa062462
- Black DM, Bilezikian JP, Ensrud KE, et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med, 353:555-565, 2005. https://doi.org/10.1056/NEJMoa050336
- Bouxsein ML, Kaufman J, Tosi L, et al. Recommendations for optimal care of the fragility fracture patient to reduce the risk of future fracture. J Am Acad Orthop Surg,12:385-395, 2004.
- Karlsson MK, Gerdhem P and Ahlborg HG. The prevention of osteoporotic fractures. J Bone Joint Surg, 87-B:1320-1327, 2005. https://doi.org/10.1302/0301-620X.87B10.16578
- Laura Gehrig, Joseph Lane J, O'Connor MI. Osteoporosis: management and treatment strategies for orthopaedic surgeons. J Bone Joint Surg, 90-A:1362-1374, 2008.
- Lewiecki EM, Miller PD, McClung MR, et al. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD. J Bone Miner Res, 22:1832-1841, 2007. https://doi.org/10.1359/jbmr.070809
- Olson K, Van Poznak C. Significance and impact of bisphosphonate-induced acute phase responses. J Oncol Pharm Pract, 13:223-229, 2007. https://doi.org/10.1177/1078155207080806
- Olson K, Van Poznak C. Significance and impact of bisphosphonate-induced acute phase responses. J Oncol Pharm Pract, 13:223-229, 2007. https://doi.org/10.1177/1078155207080806
- Rogers MJ. New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des, 9(32): 2643-2658, 2003. https://doi.org/10.2174/1381612033453640
- Romas E. Clinical applications of RANK-ligand inhibition. Intern Med J, 39:110-116, 2009. https://doi.org/10.1111/j.1445-5994.2008.01732.x
- Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA, 297:1465-1477, 2007. https://doi.org/10.1001/jama.297.13.1465
- Russell RG, Xia Z, Dunford JE, et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann NY Acad Sci, 1117:209-257, 2007. https://doi.org/10.1196/annals.1402.089
- Singer AJ and Boonen S. Osteoporosis management: translating research into optimal fracture protection II. Curr Med Res Opin, 24:1789-1796, 2008. https://doi.org/10.1185/03007990802115887
- The Korean Society of Bone Metabolism. Diagnosis and Treatment of osteoporosis. 35-88, 2008.
- http://www.nof.org/professionals/NOF_CLinicians_ Guide.pdf